$3M raised across 1 disclosed Private Placement deals.
Last updated · May 24, 2026, 5:27 PM UTC · RSS
| Date | Company | Amount | Round | Sector | Country | Lead investors |
|---|---|---|---|---|---|---|
| May 18, 26 | GeoVax Labs, Inc. GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on developing vaccines and immunotherapies for high-consequence infectious diseases and solid tumor cancers. The company is notable for its expedited regulatory pathway for its GEO-MVA vaccine targeting mpox and smallpox, with plans for a pivotal Phase 3 clinical trial in 2026. | $3.0M | Private Placement | Health | United States | — |
Filtered to your country and sector. One email per week.